Patent Assignment
Reel/Frame 060487/0522
Assignment of Assignor's Interest
Recorded: 2022-07-12
Pages: 9
Assignors
DANILKOVITCH, ALLA
Executed: 2009-09-21
NEWMAN, ROBERT E., JR.
Executed: 2009-09-21
TOM, SAMSON
Executed: 2009-09-21
TON, CHRISTOPHER
Executed: 2009-09-18
WANG, ZHANLING
Executed: 2009-09-17
YOUNG, RANDELL G.
Executed: 2009-09-22
Assignee
OSIRIS THERAPEUTICS, INC.
7015 ALBERT EINSTEIN DRIVE, COLUMBIA, MARYLAND, 21046
Covered Property
(1)
Purified Mesenchymal Stem Cell Compositions and Methods of Purifying Mesenchymal Stem Cell Compositions
Application:
16/694,382 →
Publication:
US 2020/0197444
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Assignment of Assignor's Interest
Jul 12, 2022
From: OSIRIS THERAPEUTICS, INC.
To: MESOBLAST INTERNATIONAL SÁRL
Reel/Frame 060487/0601 →
Release of Security Interest in Intellectual Property
Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →